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Many actin cytoskeleton-regulating proteins control dendritic spine morphology and
density, which are cellular features often altered in autism spectrum disorder (ASD).
Recent studies using animal models show that autism-related behavior can be rescued
by either manipulating actin regulators or by reversing dendritic spine density or
morphology. Based on these studies, the actin cytoskeleton is a potential target pathway
for developing new ASD treatments. Thus, it is important to understand how different
ASD-associated actin regulators contribute to the regulation of dendritic spines and
how ASD-associated mutations modulate this regulation. For this study, we selected
five genes encoding different actin-regulating proteins and induced ASD-associated
de novo missense mutations in these proteins. We assessed the functionality of the
wild-type and mutated proteins by analyzing their subcellular localization, and by
analyzing the dendritic spine phenotypes induced by the expression of these proteins.
As the imbalance between excitation and inhibition has been suggested to have a
central role in ASD, we additionally evaluated the density, size and subcellular localization
of inhibitory synapses. Common for all the proteins studied was the enrichment in
dendritic spines. ASD-associated mutations induced changes in the localization of
α-actinin-4, which localized less to dendritic spines, and for SWAP-70 and SrGAP3,
which localized more to dendritic spines. Among the wild-type proteins studied, only
α-actinin-4 expression caused a significant change in dendritic spine morphology
by increasing the mushroom spine density and decreasing thin spine density. We
hypothesized that mutations associated with ASD shift dendritic spine morphology from
mushroom to thin spines. An M554V mutation in α-actinin-4 (ACTN4) resulted in the
expected shift in dendritic spine morphology by increasing the density of thin spines.
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In addition, we observed a trend toward higher thin spine density withmutations inmyosin
IXb and SWAP-70. Myosin IIb and myosin IXb expression increased the proportion of
inhibitory synapses in spines. The expression of mutated myosin IIb (Y265C), SrGAP3
(E469K), and SWAP-70 (L544F) induced variable changes in inhibitory synapses.
Keywords: autism spectrum disorder, actin cytoskeleton, dendritic spines, inhibitory synapses, de novo point
mutations
INTRODUCTION
Autism spectrum disorder (ASD) comprises a range of
neurological conditions characterized by social deficits,
repetitive behaviors, and accompanying comorbidities, including
intellectual disability, epilepsy, hyperactivity, and anxiety. ASD
has a strong genetic component and almost 1000 genes are
currently associated with ASD (SFARI Gene: https://gene.sfari.
org/database/human-gene/). Many ASD-associated mutations
are rare protein-disrupting de novo mutations that arose in
the germline. Mutations can be copy-number variants (CNVs)
or single-base-pair mutations. Numerous ASD susceptibility
genes are involved in regulating the postsynaptic site of
glutamatergic synapses (Peça and Feng, 2012; Bourgeron,
2015), the development and maturation of synaptic contacts
(Gilman et al., 2011), or synaptic transmission (Li et al., 2014).
Most excitatory glutamatergic synapses are located on small
dendritic protrusions known as dendritic spines. The formation,
maturation, and elimination of dendritic spines lie at the core of
synaptic transmission and memory formation (Yang et al., 2009;
Roberts et al., 2010). Studies of postmortem human ASD brains
revealed an increased spine density, which is—at least in some
cases—the result of defective dendritic spine pruning (Tang et al.,
2014).
Numerous studies have demonstrated a pivotal role for the
actin cytoskeleton in the formation and elimination, motility and
stability, and size and shape of dendritic spines (Hotulainen and
Hoogenraad, 2010). Actin filaments are polar structures with one
end growing more rapidly (the plus or “barbed” end) than the
other (the minus or “pointed” end). Constant removal of the
actin subunits from the pointed ends and addition at the barbed
ends is called actin treadmilling. Synaptic stimulation rapidly
changes the actin treadmilling rate (Star et al., 2002; Okamoto
et al., 2004; Hlushchenko et al., 2016). The actin treadmilling
rate, as well as the three-dimensional organization of actin
filaments, are regulated by actin-binding proteins (Hotulainen
and Hoogenraad, 2010). Many actin regulators are associated
with ASD and these proteins are often involved in the regulation
of the structure and function of excitatory synapses (Joensuu
et al., 2017). However, our knowledge of whether ASD-associated
mutations in actin regulators affect their functions in dendritic
spines or synapses is limited.
Recent studies using different animal models have shown
that autistic symptoms can be rescued by either manipulating
actin regulators or by rescuing dendritic spine density or
morphology (Dolan et al., 2013; Duffney et al., 2015). Although
it is not yet clear how aberrant dendritic spines and behavioral
consequences are connected, these results suggest that actin
regulators controlling dendritic spines may play direct causal
roles in ASD-related behavior. The social deficits and NMDA
receptor hypofunction displayed by Shank3-deficient mice
were rescued by inhibiting the activity of the actin filament-
depolymerizing protein, cofilin, or by activating Rac1, the actin
cytoskeletonmaster-regulator (Duffney et al., 2015). Remarkably,
Dolan and colleagues showed that a single administration of
p21-activated kinase inhibitor, small molecule FRAX486, was
sufficient to recover the phenotype in adult Fmr1-knockout
mice, demonstrating that a post-diagnostic therapy could
be possible for Fragile-X adults (Dolan et al., 2013). p21-
activated kinase is a Rac1 effector, which regulates spines
through modulation of actin cytoskeleton dynamics. Based
on these results, the actin cytoskeleton has recently emerged
as a potential new target for new ASD treatments. Thus,
it is important to understand how different ASD-associated
actin regulators contribute to the regulation of dendritic
spines and how ASD-associated mutations modulate this
regulation.
When we started this study, the SFARI Gene Database was
not yet available. Therefore, to find ASD-associated missense
mutations in actin regulators, we relied on the gene and
mutation lists published by (Fromer et al., 2014) , which
summarized de novomutations in genes associated with different
neuropsychiatric diseases. From this list, we selected ASD-
associated genes encoding the known actin-regulating proteins:
SRGAP3, TRIO, MYO9B, MYO7B, MYH10, MYO15A, ACTN4,
SWAP70, NEB, and TTN. Nebulin (NEB) and titin (TTN) are
giant proteins (nebulin 600–900 kDa, titin up to 4.2MDa),mostly
known for their function in muscle sarcomeres. Although they
may also play roles in neurons, they were excluded from further
studies because of their large size, whichmakesmolecular biology
approaches challenging.
Next, the expression patterns of the identified genes were
investigated using the Allen Brain Atlas (mouse brain). MYO7B
was not found in the Allen Brain Atlas, and a literature
search indicated that it is not expressed in the brain (Chen
et al., 2001). MYO15A seemed to show very weak expression
in the brain. Thus, these two myosins were excluded from
further experiments. Attempts to clone TRIO constructs were
unsuccessful and therefore the final study was carried out with
five genes: ACTN4, MYO9B, SWAP70, MYH10, and SRGAP3.
The mutations we investigated are all unique, one-allele de
novo mutations leading to mixed expression of wild-type and
mutated proteins. The selected genes also have other mutations;
currently, the SFARI Gene database reports 3 variants for ACTN4
(inheritance pattern unknown or de novo), 27 variants for
MYO9B (both familial and de novo) and 4 variants for SRGAP3
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(all de novo). SWAP70 and MYH10 are not listed in the SFARI
Gene database.
Alpha(α)-actinin-4 (ACTN4) is expressed in the
hippocampus, cortex, and cerebellum in the brain (Kalinowska
et al., 2015). The main function of α-actinins is to cross-link actin
filaments into bundles (Otey and Carpen, 2004). Cross-linking
actin filaments provides the rigidity and stability for filaments.
In neurons, α-actinin-4 is enriched at excitatory synapses and
co-localizes with group 1 metabotropic glutamate receptors
(mGluRs) (Kalinowska et al., 2015). α-actinin-4 supports the
transition of thin spines to mushroom spines and is required
for the mGluR-induced dynamic remodeling of dendritic
protrusions (Kalinowska et al., 2015).
Non-muscle myosin IIb (MYH10), or non-muscle myosin
heavy chain IIb (NMMHCIIb) (referred to here as myosin
IIb) is important for the normal development and function
of dendritic spines (Zhang, 2005; Ryu et al., 2006; Rex et al.,
2010; Hodges et al., 2011) and is re-located into dendritic
spines during neuronal maturation (Ryu et al., 2006). Myosin
IIb localizes to the base of mushroom spine heads (Korobova
and Svitkina, 2010; Rubio et al., 2011) where it facilitates the
stabilization of spines through actin cross-linking (Koskinen
et al., 2014). Simultaneously, myosin IIb-induced contractility
enhances the dynamics of actin filaments on the spine surface,
thus facilitating the fast fine-tuning of spine shape (Koskinen
et al., 2014). The MYH10 gene is associated with various
neurological diseases, such as schizophrenia and autism (Fromer
et al., 2014).
The humanmyosin IXb (MYO9B) protein is mostly studied in
cancer cell lines, where it localizes to sites of actin polymerization
(van den Boom et al., 2007). However, myosin IXb is also
expressed in the central nervous system. In cortical neurons,
it controls RhoA activity, thereby regulating the growth and
branching of dendritic processes (Long et al., 2013). Knockdown
of myosin IXb in cultured cortical neurons or in the developing
cortex results in decreased dendrite length and number (Long
et al., 2013).
SWAP-70 (SWAP70) takes part in DNA recombination in
the nucleus (Borggrefe et al., 1998) and regulates the actin
cytoskeleton in the cytosol (Hilpelä et al., 2003; Chacón-Martínez
et al., 2013). SWAP-70 binds the plasma membrane through the
binding of its plecstrin homology domain to phosphoinositide
PI(3,4)P2 (Hilpelä et al., 2003). SWAP-70 was identified as an
interaction partner of myosin IXb in a two-hybrid screening
(Hilpelä et al., 2003), but this putative interaction remains to
be confirmed. Although SWAP-70 is expressed in the brain
(Hilpelä et al., 2003), its function has not been studied in
neurons.
SLIT-ROBORhoGTPase-activating protein 3 (SrGAP3, Gene:
SRGAP3) is ubiquitously expressed in the developing nervous
system (Bacon et al., 2009, 2013). SrGAP3 supports the initiation
of spines and inhibits the transition of thin spines to mushroom
spines. Knocking out SrGAP3 decreases the number of dendritic
filopodia during early mouse development (Carlson et al., 2011).
The most commonly observed dendritic spine phenotype
associated with ASD is an increased density of thin spines
(Comery et al., 1997). Thus, our main hypothesis was that genetic
mutations associated with ASD shift dendritic spine morphology
frommushroom spines to thin spines. To test this hypothesis, we
studied how ASD-associated single base-pair de novo mutations
in five selected genes affect the localization and function of
the encoded proteins, and whether these mutations change the
proteins’ overexpression effects on dendritic spine density and
morphology in primary rat hippocampal neurons.
As the imbalance between excitation and inhibition has
been suggested to have a central role in ASD (Rubenstein
and Merzenich, 2003; Südhof, 2008; Uzunova et al., 2016; Lee
et al., 2017), we analyzed the density and size of inhibitory
synapses. Postmortem neuropathological studies of people with
ASD have demonstrated a decreased density of GABA receptors
in the cortex (Blatt and Fatemi, 2011). In mouse models, both
upregulation and suppression in inhibitory synaptic transmission
have been detected (Isshiki et al., 2014). Thus, we did not
have clear expectations regarding the kind of changes we
should see. Therefore, we hypothesized that there are alterations
in the size and density of inhibitory synapses in neurons
expressing proteins with ASD-linked mutations. We further
hypothesized that the localization of inhibitory synapses in
spines vs. dendritic shafts affects the efficiency or modality
of inhibition. Thus, we also analyzed the ratio of inhibitory
synapses in spines vs. dendritic shaft. None of the proteins
studied was found to be part of the inhibitory synapse complex
(Uezu et al., 2016) so we did not expect them to directly
regulate inhibitory synapses. However, these proteins could affect
inhibitory synapse dynamics and thus their localization, size and




pEGFP-N1 and mCherry-C1 plasmids were purchased from
Clontech Laboratories Inc. Wild-type mCherry-tagged α-
actinin 4 (ACTN4) and Slit-Robo GAP3 (SRGAP3) were
generated at the Genome Biology Unit cloning service (Biocenter
Finland, University of Helsinki). Briefly, entry clones [clone-
IDs: 100011237 (ACTN4) and 100069053 (SrGAP3)] from
the human ORFeome collaboration library were transferred
into mCherry-tagged mammalian expression destination
vectors using standard LR Gateway cloning. mCherry-tagged
SWAP-70, myosin IXb, and myosin IIb constructs were
kind gifts from Martin Bähler (SWAP-70 and Myosin IXb,
WestfalianWilhelms-University, Münster, Germany) and
Alan Rick Horwitz (MHCIIb, University of Virginia, USA).
Mutant constructs were generated through PCR-mediated
site-directed mutagenesis (Zheng et al., 2004). Purified PCR
products were treated for 2 h using DpnI (New England
Biolabs) and 5 µl were used to transform competent DH5-α
cells. Transformants were inoculated on LB plates containing
appropriate antibiotics for selection and 5 colonies were
selected for mini-prep. All wild-type and mutated constructs
were verified by DNA sequencing. The primers used for each
mutation are listed in Table 1. Mutagenized bases are listed in
lower-case.
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TABLE 1 | The primers used for each mutation.
Construct Mutation Primers




















Plasmids were first tested in U2OS cells to confirm that they
were expressed and localized as expected (data not shown).
Neuronal Cultures, Transfections,
Immunofluorescence, and Fixed Sample
Preparation
Hippocampal neuronal cultures were prepared as described
previously (Bertling et al., 2012). Animals were handled in
accordance with Finnish laws and ethics under the EU directive
2010/63/EU (licenses: ESAVI-4943-04.10.07-2016 and GMO
3/S/12). Briefly, the hippocampi of embryonal day 17 Wistar rat
fetuses of either sex were dissected and brains obtained. The
meninges were then removed and hippocampi isolated. Cells
were dissociated with 0.05% papain and mechanical trituration.
The cells were plated on coverslips (diameter 13mm) coated
with 0.1 mg/ml Poly-L-Lysine (Sigma) at a density of 150,000
cells per coverslip and cultured in Neurobasal medium (Gibco)
supplemented with B-27 (Invitrogen), L-glutamine (Invitrogen)
and penicillin–streptomycin (Lonza). Transient transfections
were performed, as described earlier (Hotulainen et al., 2009), on
DIV13-14 using Lipofectamine 2000 (Invitrogen). The neurons
were then fixed on DIV 15-16 with 4% PFA for 20min, then
washed 3 times with PBS. For inhibitory synapse labeling, the
cells were then permeabilized with 0.2% TritonX-100 in PBS
for 10min and then blocked with 3% normal donkey serum
and 0.5% BSA in PBS for 30min. Antibodies were diluted
separately in blocking solution at 1:500 for primary anti-gephyrin
antibody (rabbit, Synaptic Systems) and 1:400 for secondary
Alexa-488 (anti-rabbit, Molecular probes), and subsequently 25
µl was dropped onto a parafilm that was then covered by
the coverslip. Each antibody was incubated for 1 h at room
temperature. The coverslips were washed 3 times for 10min
with 0.2% BSA in PBS after each incubation, then mounted
on microscope slides using Shandon Immu-Mount (Thermo
Scientific).
Confocal Imaging and Protein Localization
Analysis
Imaging was performed on either a Zeiss LSM780 or LSM880
inverted confocal microscope. A 63× 1.4 NA oil immersion
objective lens and Immersol 518F (Zeiss) immersion oil were
used to image the fixed samples. For each neuron, a z-stack
of 20–30 optical sections was obtained with 0.2–0.3µm steps
in the z axis and a pixel size of 0.066 × 0.066µm for 1–2
dendritic segments. Image files were processed with Zeiss ZEN
and Fiji software (Schindelin et al., 2012, 2015). Fiji software
was used to calculate spine–to-dendrite intensity ratios. First, 3D
image data was converted to 2D using Z-projection based on
maximum intensity. To measure the ratio, the average intensity
of fluorescence for the protein of interest was measured from a
circular region of interest (ROI) in the spine head and compared
to the average fluorescence intensity of the equal-sized ROI in
the adjacent dendrite. The result was normalized to the intensity
distribution of GFP in the same ROIs. For each neuron 9–10
spines were analyzed and the median value was then taken as
representative for the cell. Therefore, for each group we analyzed
at least 140 spines. Box plots were then created using a BoxPlotR
web-tool (http://shiny.chemgrid.org/boxplotr/).
Dendritic Spine Morphology and Density
Analysis
For the analysis of spine density and morphology, tiff image
files comprising z-stacks of 20–30 optical sections per dendritic
segment were directly processed with NeuronStudio, a software
package specifically designed for spine detection and analysis
(Rodriguez et al., 2008). The voxel size of the images was 0.066
× 0.066 × 0.2–0.3µm. The EGFP signal was used to analyze
dendritic morphology. After modeling the dendrite surface,
the spines were auto-detected and classified as “mushroom,”
“thin,” or “stubby” by the software. The model was then
corrected manually: the protrusions missed by the algorithm
were added and classified, the false labeling of other structures
as spines was removed. Protrusions with a length between 0.1
and 5µm, and width between 0.1 and 3µm were retained as
spines. Measurements obtained by NeuronStudio were further
processed in MATLAB R2015a to extract spine number, lengths,
head widths, and the total length of dendritic segments, and
summarized in a spreadsheet application (MS Excel).
Density and Size Analysis of Inhibitory
Synapses
Fiji software was used for the analysis of the density and size
of inhibitory synapses. 3D images were opened in Fiji and used
to create maximum intensity projections. The “straight line”
tool was used to measure the length of the selected portion
of the image. Lines were drawn, and the length was measured
along the length of a dendrite. The data was then copied
to an excel file and the sum of all the lines obtained gave
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FIGURE 1 | Location of the mutated amino acid in the α-actinin structure. (A) Primary structure of human α-actinin-4 with the M554V mutation indicated. (B)
Structure of human α-actinin-2 (PDB ID 4D1E) with methionine corresponding to the α-actinin-4 M554 and surrounding residues highlighted (close-up).
the total length of the dendrite/s. The number of individual
inhibitory synapses along the dendrite and the dendritic spines,
indicated by bright green dots, was determined. Dots smaller
than 0.1µm were disregarded. The same “straight line” tool was
used to measure the diameter of each synapse. The density,
percentage of synapses on spines, and average diameter of
synapses for inhibitory synapses was then calculated from the
data obtained.
Statistics
Statistical analysis was performed with the SPSS Statistics
software package. To examine group differences, one-way
ANOVA was used with Bonferroni post-hoc test when
the compared groups’ variances were equal and Games-
Howell post-hoc test when the variances were unequal.
To examine the difference in spine length, width, and
width-to-length ratio distributions between the groups, we
used the 2-sample Kolmogorov-Smirnov nonparametric
test.
Figures and Molecular Modeling
All structural figures were generated with PyMol software (The
PyMOL Molecular Graphics System, Version 2.0 Schrödinger,
LLC). Images were prepared for the publication using standard
tools of Fiji software (Schindelin et al., 2012, 2015). The bar
charts were created in MS Excel and the cumulative distribution
curves in MATLAB R2015a. The final figure layouts were
generated with Inkscape: Open Source Scalable Vector Graphics
Editor.
Availability of Materials and Data
All material and data (pictures, plasmids, analyses) are available
upon request.
RESULTS
α-Actinin-4 Point Mutation M554V Alters
Localization and Overexpression-Induced
Dendritic Spine Phenotype
Iossifov et al. (2012) identified a missense A to G change in
the ACTN4 gene in a child exhibiting ASD symptoms. This
base change leads to an amino acid substitution [methionine
(M) 554 to valine (V)] in the spectrin repeat-3 of the α-
actinin-4 protein (Figure 1A). The formation of homodimers
is required for efficient α-actinin actin filament cross-linking
activity. As the M554V mutation localizes to the known binding
interface of the α-actinin homodimer (Ylänne et al., 2001)
(Figure 1B), we hypothesized that this mutation may prevent
or interfere with the correct assembly of cellular actin filament
bundles.
To analyze the effects of M554V on α-actinin-4 subcellular
localization, we transfected primary rat hippocampal neurons
at days-in-vitro (DIV) 13 and analyzed the ratio of spine
to dendritic localization of mCherry, human wild-type α-
actinin-4 linked to mCherry, or mCherry-M554V-α-actinin-
4 at DIV15. Fluorescence intensity was normalized to co-
expressed EGFP (Figure 2A). Both α-actinin-4 constructs were
expressed at similar levels in the cells analyzed. Wild-type
α-actinin-4 was highly enriched in dendritic spines at a
ratio of 6.64 ± 0.50 compared to diffuse GFP with a ratio
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FIGURE 2 | Characterization of protein localization, dendritic spine density and morphology in DIV14-15 hippocampal neurons expressing EGFP and mCherry
(control), wild-type α-actinin-4-mCherry or mutated α-actinin-4-M554V-mCherry. (A) Representative maximum projections of confocal Z-stacks for EGFP, mCherry,
and wild-type and mutated α-actinin-4 localization. Scale bars, 4µm. (B) The quantification of protein localization revealed enrichment of wt α-actinin-4 to dendritic
spines and the decrease in accumulation for α-actinin-4-M554V. Spine-to-dendrite fluorescence intensity ratios: control: 0.98 (n = 34 cells, 339 spines), α-actinin-4:
6.64 (n = 26 cells, 260 spines), α-actinin-4-M554V: 4.1 (n = 30 cells, 299 spines). Center lines show the medians; box limits indicate the 25th and 75th percentiles
(Continued)
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FIGURE 2 | as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles, outliers are represented by dots;
crosses represent sample means. ***p < 0.001 as determined by one-way ANOVA test with Games-Howell post-hoc test. (C) Maximum projections of confocal
Z-stacks of dendrites from neurons overexpressing EGFP along with either mCherry, α-actinin-4-mCherry or α-actinin-4-M554V-mCherry. Only EGFP channel is
shown and was used to assess spine density and morphology. Scale bar, 4µm. (D) Quantification of dendritic spine density calculated as number of spines per 1µm
of dendrite. The first left cluster of bars represents total spine density. Densities of thin, mushroom, stubby, and total spines were as follows: wt: thin = 0.25,
mushroom = 0.15, stubby = 0.07, total = 0.48 spines/µm (n = 34 neurons, 1,937 spines, 4,091µm dendrite); α-actinin-4: thin = 0.18, mushroom = 0.21, stubby =
0.08, total = 0.46 spines/µm (n = 26 neurons, 1,229 spines, 2,816µm dendrite); α-actinin-4-M554V: thin = 0.24, mushroom = 0.18, stubby = 0.09, total = 0.51
spines/µm (n = 30 neurons, 1,750 spines, 3,573µm dendrite). Data is pooled from 4 experiments and represented as mean ± SEM. *p < 0.05, **p < 0.01 as
determined by one-way ANOVA test with Bonferroni post-hoc test. (E) Cumulative distributions of the width, length and the ratio of width to length of dendritic spines
for neurons expressing either mCherry (control), α-actinin-4-mCherry or α-actinin-4-M554V-mCherry. Curves are a combination of data points each representing an
individual spine. Matching tail regions of the curves are not shown. *p < 0.05, ***p < 0.001 as determined by pairwise two-sample Kolmogorov-Smirnov test.
of 0.98 ± 0.01 (Figures 2A,B, Table 2). M554V-α-actinin-4
also localized to dendritic spines—albeit to a much lesser
extent than wild-type α-actinin-4 at a ratio of 4.10 ± 0.29
(Figures 2A,B).
To assess possible changes in dendritic spines, we analyzed
dendritic spine morphology and density in neurons co-
transfected with EGFP and wild-type or mutated α-actinin-4-
mCherry. Dendritic spine density andmorphology were analyzed
using the NeuronStudio software (Rodriguez et al., 2008) using
EGFP intensity. The overexpression of wild-type α-actinin-
4 resulted in an increase in mushroom spine density, while
mutated α-actinin-4 failed to induce such an increase when
compared to control cells expressing mCherry (Figures 2C,D).
Thin spine density was decreased in wild-type α-actinin-4
expressing cells compared to control cells, whereas in mutant α-
actinin-4 expressing cells the thin spine density was significantly
increased compared to wild-type expressing cells (Figures 2C,D,
Table 2). The cumulative distributions of spine head width,
length, and width-to-length ratios showed some significant
differences. Wild-type—but not mutant—overexpressing cells
had a higher proportion of spines with wider heads in the range of
0.2–0.8µm, whereas both wild-type and mutant overexpressing
cells had slightly higher proportions of shorter spines in the range
of 0.5–2.5µm (Figure 2E). From the distributions of width-to-
length ratios of spines we can see that in cells overexpressing
wild-type or mutant α-actinin-4, more spines possessed mature
morphology (i.e., wide head, short neck) compared to controls.
This suggests that changes in spine widths and lengths occur
proportionally in the same spines. Taken together, these results
show that mutated α-actinin-4 is less concentrated in dendritic
spines and fails to mimic the effect of the wild-type protein on
dendritic spine morphology.
Next, we analyzed the density and size of inhibitory synapses,
as well as the proportion of inhibitory synapses in spines, by
visualizing inhibitory synapses using gephyrin antibody staining.
To check the specificity of gephyrin staining, we co-stained
cells with the pre-synaptic VGAT antibody (Figure 3). This co-
staining showed co-localization between gephyrin puncta and the
presynaptic VGATmarker, ruling out the possibility of unspecific
gephyrin staining (Figure 3). Analysis of gephyrin puncta
revealed that the overexpression of wild-type α-actinin-4 reduced
the density of inhibitory synapses (Figure 4, Table 2). However,
the change varied between experiments and, therefore, this
result did not reach statistical significance. Mutated α-actinin-4
enhanced this effect of wild-type protein and the difference
between mutant α-actinin-4 and control cells was significant
(Figure 4B). The changes in synapse size or the proportion of
synapses on dendritic spines were not significant (Figure 4B).
In summary, we found that M554V point mutation in α-
actinin-4 reduces the localization of α-actinin-4 to dendritic
spines. The expression of α-actinin-4-M554V in hippocampal
neurons resulted in an increased thin spine density compared
to the expression of wild-type α-actinin-4. The mutation in α-
actinin-4 enhanced the effect of wild-type protein in decreasing
the inhibitory synapse density, and the difference in density
between control and mutant α-actinin-4 expressing neurons was
significant. These results suggest that the ASD-associatedM554V
mutation leads to a loss-of–function or reduced-function effect
in α-actinin-4 in the regulation of dendritic spines. However,
this mutation enhances the effect of wild-type α-actinin-4 in
inhibitory synapses (Table 2).
Myosin IIb Mutation Y265C Expression
Reduces Inhibitory Synapse Size and the
Proportion of Inhibitory Synapses in Spines
A de novo missense mutation T to C in the MYH10 gene
was found by whole exome sequencing of parent–child trios
exhibiting sporadic ASD (O’Roak et al., 2012) (Figures 5A,B).
This base change leads to the substitution of tyrosine-265 (Y265)
to cysteine (C) in the myosin IIb protein. Y265 is located in
the center of the myosin IIb motor domain and participates
in a potentially stabilizing hydrogen bond interaction with the
neighboring glutamate-263. These residues are distal from the
motor domain ATP binding site but could contribute to the
ATPase activity by affecting the stability and overall folding of
this domain (Figures 5A,B).
As expected from earlier work (Korobova and Svitkina,
2010; Rubio et al., 2011), wild-type myosin IIb localized to
the base of the spine head, showing enrichment in spines vs.
dendrites (Figures 6A,B). The mutated myosin IIb exhibited
similar localization (Figures 6A,B). Spine analysis did not reveal
any differences in spine density between control, myosin IIb
wild-type, and myosin IIb-Y265C (Figures 6C,D). Cumulative
distribution analysis showed slight changes in spine morphology
(Figure 6E). Neurons overexpressing wild-type myosin IIb
exhibited a smaller proportion of wider spines compared
to controls and neurons overexpressing myosin-IIb-Y265C.
Mutant-expressing neurons showed an increased fraction of
wider spines and a decreased proportion of long spines compared
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TABLE 2 | Result summary table.
Comparison of wild-type (wt) protein phenotypes to control phenotype and mutant expression phenotype to wild-type phenotype
α-actinin-4 Myosin IIb Myosin IXb SWAP-70 SrGAP3
Localization to spines (ratio spine/shaft)
Ctrl vs. wt 0.98 vs. 6.64 0.93 vs. 1.73 0.92 vs. 1.65 0.98 vs. 1.15 0.99 vs. 1.32
Ctrl vs. mut 0.98 vs. 4.1 0.93 vs. 1.79 0.92 vs. 1.61 0.98 vs. 1.78 0.99 vs. 1.42
wt vs. mut 6.64 vs. 4.1 1.73 vs. 1.79 1.65 vs. 1.61 1.15 vs. 1.78 1.32 vs. 1.42
Total spine density (spines/µm)
Ctrl vs. wt 0.48 vs. 0.46 0.55 vs. 0.57 0.48 vs. 0.44 0.39 vs. 0.46 0.45 vs. 0.54
Ctrl vs. mut 0.48 vs. 0.51 0.55 vs. 0.61 0.48 vs. 0.49 0.39 vs. 0.54 0.45 vs. 0.54
wt vs. mut 0.46 vs. 0.51 0.57 vs. 0.61 0.44 vs. 0.49 0.46 vs. 0.54 0.54 vs. 0.54
Thin spine density (spines/µm)
Ctrl vs. wt 0.25 vs. 0.18 0.25 vs. 0.27 0.24 vs. 0.24 0.19 vs. 0.25 0.23 vs. 0.29
Ctrl vs. mut 0.25 vs. 0.24 0.25 vs. 0.27 0.24 vs. 0.27 0.19 vs. 0.31 0.23 vs. 0.28
wt vs. mut 0.18 vs. 0.24 0.27 vs. 0.27 0.24 vs. 0.27 0.25 vs. 0.31 0.29 vs. 0.28
Mushroom spine density (spines/µm)
Ctrl vs. wt 0.15 vs. 0.21 0.20 vs. 0.21 0.18 vs. 0.15 0.16 vs. 0.18 0.16 vs. 0.18
Ctrl vs. mut 0.15 vs. 0.18 0.20 vs. 0.22 0.18 vs. 0.15 0.16 vs. 0.18 0.16 vs. 0.19
wt vs. mut 0.21 vs. 0.18 0.21 vs. 0.22 0.15 vs. 0.15 0.18 vs. 0.18 0.18 vs. 0.19
Total spine head size (µm)
Ctrl vs. wt 0.46 vs. 0.46 0.49 vs. 0.43 0.46 vs. 0.42 0.44 vs. 0.44 0.44 vs. 0.45
Ctrl vs. mut 0.46 vs. 0.46 0.49 vs. 0.49 0.46 vs. 0.43 0.44 vs. 0.40 0.44 vs. 0.45
wt vs. mut 0.46 vs. 0.46 0.43 vs. 0.49 0.42 vs. 0.43 0.44 vs. 0.40 0.45 vs. 0.45
Inhibitory synapse density (synapses/µm)
Ctrl vs. wt 0.40 vs. 0.31 0.37 vs. 0.45 0.37 vs. 0.37 0.38 vs. 0.38 0.37 vs. 0.41
Ctrl vs. mut 0.40 vs. 0.25 0.37 vs. 0.39 0.37 vs. 0.40 0.38 vs. 0.28 0.37 vs. 0.51
wt vs. mut 0.31 vs. 0.25 0.45 vs. 0.39 0.37 vs. 0.40 0.38 vs. 0.28 0.41 vs. 0.51
Inhibitory synapse size (µm)
Ctrl vs. wt 0.43 vs. 0.44 0.44 vs. 0.46 0.44 vs. 0.48 0.42 vs. 0.38 0.44 vs. 0.38
Ctrl vs. mut 0.43 vs. 0.44 0.44 vs. 0.42 0.44 vs. 0.44 0.42 vs. 0.40 0.44 vs. 0.39
wt vs. mut 0.44 vs. 0.44 0.46 vs. 0.42 0.48 vs. 0.44 0.38 vs. 0.40 0.38 vs. 0.39
Proportion of inhibitory synapses in spines vs. shaft
Ctrl vs. wt 0.38 vs. 0.37 0.33 vs. 0.43 0.33 vs. 0.41 0.34 vs. 0.37 0.33 vs. 0.33
Ctrl vs. mut 0.38 vs. 0.31 0.33 vs. 0.34 0.33 vs. 0.39 0.34 vs. 0.34 0.33 vs. 0.42
wt vs. mut 0.37 vs. 0.31 0.43 vs. 0.34 0.41 vs. 0.39 0.37 vs. 0.34 0.33 vs. 0.42
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Values obtained from wild-type (ctrl vs. wt) or mutated protein (ctrl vs. mut) expressing cells are compared to control cells, and values obtained from cells expressing wild-type proteins
are compared to values of mutant protein expressing cells (wt vs. mut). A statistically significant (p < 0.05) increase is highlighted with green and decrease with blue.
to wild-type myosin IIb-expressing neurons. In summary, only
minor changes in dendritic spines were observed upon myosin
IIb-Y265C over-expression.
The analysis of inhibitory synapses showed that wild-
type myosin IIb expression increased the proportion of
inhibitory synapses in spines compared to control cells
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FIGURE 3 | Inhibitory synapse localization in a DIV15 hippocampal neuron
expressing mCherry and stained with postsynaptic anti-gephyrin (Alexa-488)
and presynaptic anti-VGAT (Alexa-594) antibodies. In overlay, mCherry is
shown in red, anti-gephyrin antibody staining in green, and anti-VGAT antibody
staining in magenta. The line indicates the contour of dendrites (from
mCherry). Scale bar, 5µm.
(Figures 7A,B, Table 2). In contrast, mutant-expressing cells
had fewer inhibitory synapses located on dendritic spines
compared to wild-type overexpressing neurons (Figures 7A,B,
Table 2). Moreover, the size of inhibitory synapses was smaller in
neurons overexpressing myosin IIb-Y265C compared to neurons
expressing wild-type myosin IIb.
In summary, the Y265C-mutation induced slight changes in
themorphology and size of dendritic spines compared to neurons
expressing wild-type myosin IIb. The expression of the mutant
reduced the size of inhibitory synapses and the proportion of
inhibitory synapses located on spines, compared to wild-type
expression.
Myosin IXB Increases the Proportion of
Inhibitory Synapses in Spines
Whole exome sequencing applied to families with an ASD child
revealed A/G de novo missense mutations in the MYO9B gene
leading to an amino acid change [lysine (K) 1872 to arginine (R)]
in the RhoGAP domain of the myosin IXb protein (Iossifov et al.,
2014) (Figure 8A). K1872 is involved in a stabilizing salt-bridge
interaction with E1796 within the RhoGAP domain. However,
it is not likely that the conservative lysine to arginine mutation
would result in significant domain destabilization or functional
change (Figures 8A,B).
Over-expression of wild-type and myosin IXb-K1872R-
mCherry constructs revealed enrichment in spine heads 1.6
times that of mCherry (Figures 9A,B). Spine analysis revealed
no significant changes in spine density in neurons expressing
either wild-type or myosin IXb-K1872R-mCherry constructs
(Figures 9C,D, Table 2). Thin spine density was slightly
increased in neurons expressing mutated myosin IXb, but this
change did not reach statistical significance. Examination of the
cumulative distribution of spine morphological aspects such as
width, length, and width-to-length ratio showed only minor
differences (Figure 9E). Neurons expressing wild-type or myosin
IXb-K1872R had a marginally higher proportion of thinner
spines in the range of 0.3–0.7µm. The lengths and width-to-
length ratios of spines had very comparable distributions for all
three groups (Figure 9E).
Wild-type myosin IXb expression increased the proportion of
inhibitory synapses compared to control cells (Figures 10A,B,
Table 2). The K1872R mutation did not cause any significant
changes in inhibitory synapses when compared to wild-type
expression.
SWAP-70 Mutant L544F Expression
Enhances Localization to Spines and
Reduces the Spine Width and Inhibitory
Synapse Density
Whole exome sequencing of families with an ASD child revealed
a de novo missense mutation A/T in SWAP70, leading to an
amino acid change of leucine (L) 544 to phenylalanine (F) in
the C-terminus of SWAP-70 (Figure 11A). The C-terminus of
SWAP-70 (amino acids 525–585) is known to be critical for actin
binding (Ihara et al., 2006), so a mutation in this region could
putatively affect the protein’s actin binding properties.
Wild-type SWAP-70 was slightly enriched in dendritic spines
when expressed as an mCherry fusion protein in neurons
(Figures 11B,C). SWAP-70 L544F-mutation significantly
enhanced the spine localization (Figures 11B,C, Table 2). Spine
analysis showed increased total and thin spine density for
SWAP-70 expressing neurons. The L544F-mutation enhanced
these effects, and the difference between cells expressing
mutated SWAP-70 and cells expressing mCherry was statistically
significant (Figures 11D,E). On average, spine protrusion
lengths or head widths in SWAP-70-overexpressing cells were
not different from control. However, with the introduction
of the mutant SWAP-70-L544F, dendritic spines became
thinner (average head width of 0.40 ± 0.01µm for the mutant
vs. 0.44 ± 0.01µm for wild-type, p < 0.05) compared to
wild-type SWAP-70. In addition, the distribution of spine
morphology parameters showed a similar change toward an
increased proportion of thin and short spines (Figure 11F). The
density of inhibitory synapses was significantly decreased in
mutant-overexpressing neurons compared to both control
and wild type-overexpressing neurons (Figures 12A,B,
Table 2).
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FIGURE 4 | Characterization of the inhibitory synapses in DIV15 hippocampal neurons expressing either mCherry (control), wild-type α-actinin-4-mCherry or
α-actinin-4-M554V-mCherry and stained with anti-gephyrin antibody. (A) In overlay, mCherry is shown in magenta and anti-gephyrin antibody staining in green. The
line indicates the contour of dendrites (from mCherry). Scale bars, 5µm. (B) Quantification of inhibitory synapse properties. From left to right: (1) Mean density of
synapses calculated as the number of gephyrin puncta per µm of the dendrite: control = 0.40; α-actinin-4 = 0.31; α-actinin-4-M554V = 0.25. (2) Mean diameter of
individual gephyrin puncta in µm: control = 0.43; α-actinin-4 = 0.44; α-actinin-4-M554V = 0.44. (3) Proportion of the gephyrin puncta located on dendritic spines as
a fraction of the total number of puncta: control = 0.38; α-actinin-4 = 0.37; α-actinin-4-M554V = 0.31. Data in (B) represent n(control) = 19 cells, n(α-actinin-4) = 21
cells, n(α-actinin-4-M554V) = 20 cells, pooled from 3 experiments. **p < 0.01 as determined by one-way ANOVA with Bonferroni’s post-hoc test. Data is represented
as mean ± SEM.
Taken together, wild-type SWAP-70 was neither enriched
in dendritic spines, nor did its overexpression alter
dendritic spine density or morphology. Wild-type SWAP-
70 overexpression did not affect inhibitory synapses either.
In contrast, mutated SWAP-70 was enriched in dendritic
spines and its overexpression changed the morphology of
spines, making them narrower. It also reduced the density
of inhibitory synapses by almost 30% compared to wild-type
expressing cells (Figure 12B). We conclude that the SWAP-
70-L544F mutation changes its function from a non-synaptic
regulator to a regulator of dendritic spines and inhibitory
synapses.
SrGAP3 Mutant E469K Expression
Enhances Localization to Spines and
Increases the Proportion of Inhibitory
Synapses in Spines
A de novo C/T missense variant in the SRGAP3 gene was
identified in an ASD proband (Sanders et al., 2012). In the
SrGAP3 protein, this mutation changes glutamic acid-469 to
lysine (E469K), thus changing the charge of the amino acid
(Figure 13A).
The mutated SrGAP3 construct enhanced the dendritic spine
localization of SrGAP3 (Figures 13B,C). Spine analysis showed
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FIGURE 5 | Location of the mutated amino acid in the myosin IIb structure. (A) Primary structure of human myosin IIb with the Y265C mutation indicated. (B)
Structure of human myosin IIb (PDB ID 4PD3) with residue Y265 and surrounding residues highlighted (close-up).
a significant increase in the density of total and thin spines in
neurons that overexpressed SrGAP3-E469K compared to control
neurons (Figures 13D,E). We did not observe any difference
in the distribution of head widths, lengths, or width-to-length
ratios between all 3 groups (Figure 13F). SrGAP3 wild-type
expression decreased the size of inhibitory synapses, whereas
the expression of mutated SrGAP3 increased the proportion of
inhibitory synapses in spines compared to wild-type SrGAP3
expression (Figures 14A,B).
These results show that the E469K mutation enhances the
localization of SrGAP3 to dendritic spines. Both wild-type
and mutated SrGAP3 increased the density of total and thin
spines, and the change between the control andmutated-SrGAP3
groups was statistically significant. The mutation also changed
the location of inhibitory synapses by increasing their ratio in
dendritic spines.
DISCUSSION
Both genetic and anatomical studies suggest an important
role for defective synapse or spine regulation in ASD. Many
actin-modulating proteins known to regulate dendritic spine
morphology and density are associated with ASD (Joensuu et al.,
2017). However, current knowledge about the mutational effects
of these proteins is poor. This has hampered the ability to
deduce the prevalence of common defects or cellular phenotypes
across different genes and mutations. Based on current literature,
we concluded that dendritic spines and inhibitory synapses
are good parameters to test the functional consequences of
mutations. Dendritic spines are especially suitable because three
of the proteins studied (α-actinin-4, myosin IIb, and SrGAP3)
have known functions in regulating dendritic spine density and
morphology (Zhang, 2005; Ryu et al., 2006; Rex et al., 2010;
Carlson et al., 2011; Hodges et al., 2011; Kalinowska et al., 2015).
The selection of these parameters was also favored by the fact
that both dendritic spines and inhibitory synapses are relatively
easy to analyze and could therefore be used for high-throughput
screening in future studies. Synaptic transmission would have
been another parameter to evaluate, but because the depletion
and overexpression of α-actinin-4 resulted in no change in basal
synaptic transmission (Kalinowska et al., 2015), we estimated
that it is more plausible to detect changes in dendritic spine
morphology.
The proper localization of proteins is critical for their correct
functioning. Thus, we first analyzed the localization of wild-type
and mutated proteins (results summarized in Table 2). Common
for all the proteins studied was the enrichment in dendritic
spines, suggesting that they can have a role in the regulation
of dendritic spine number or morphology. Localization analysis
confirmed earlier published results for α-actinin-4 (Kalinowska
et al., 2015), myosin IIb (Korobova and Svitkina, 2010; Rubio
et al., 2011), and SrGAP3 (Carlson et al., 2011). The mutations
induced changes in the localization of α-actinin-4, which
localized less to dendritic spines, and for SWAP-70 and SrGAP3,
which localized more to dendritic spines. These results show that
single amino acid changes can affect the subcellular localization
of proteins and a mutation can either reduce (loss-of-function)
or induce (gain-of-function) a specific localization.
Next, we studied whether these mutations affect the
proteins’ overexpression effects on dendritic spine density and
morphology in primary hippocampal neurons. Among the
wild-type proteins studied, only α-actinin-4 overexpression
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FIGURE 6 | Characterization of protein localization, dendritic spine density and morphology in DIV14-15 hippocampal neurons expressing EGFP and mCherry
(control), myosin-IIb-mCherry or mutated myosin-IIb-Y265C-mCherry. (A) Representative maximum projections of confocal Z-stacks for EGFP, mCherry, and wild-type
and mutated myosin-IIb localization. Scale bars 4µm. (B) The quantification of protein localization revealed similar enrichment for both wt and mutated myosin-IIb to
dendritic spines. Spine-to-dendrite fluorescence intensity ratios: control: 0.93 (n = 17 cells, 170 spines), myosin-IIb: 1.73 (n = 17 cells, 170 spines), myosin-IIb-Y265C
1.79 (n = 18 cells, 180 spines). Center lines show the medians; box limits indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5
(Continued)
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FIGURE 6 | times the interquartile range from the 25th and 75th percentiles, outliers are represented by dots; crosses represent sample means. ***p < 0.001 as
determined by one-way ANOVA test with Games-Howell post-hoc test. (C) Maximum projections of confocal Z-stacks of dendrites from neurons overexpressing
EGFP along with either mCherry, myosin-IIb-mCherry, or myosin-IIb-Y265C-mCherry. Only EGFP channel is shown and was used to assess spine density and
morphology. Scale bar, 4µm. (D) Quantification of dendritic spine density calculated as number of spines per 1µm of dendrite. The first left cluster of bars represents
total spine density. Densities of thin, mushroom, stubby, and total spines were as follows: wt: thin = 0.25, mushroom = 0.2, stubby = 0.1, total = 0.55 spines/µm
(n = 17 neurons, 1,825 spines, 3,354µm dendrite); myosin-IIb: thin = 0.27, mushroom = 0.2, stubby = 0.09, total = 0.57 spines/µm (n = 17 neurons, 1,718 spines,
3,459µm dendrite); myosin-IIb-Y265C: thin = 0.27, mushroom = 0.22, stubby = 0.12, total = 0.61 spines/µm (n = 18 neurons, 2,253 spines, 3,877µm dendrite).
Data is pooled from 2 experiments and represented as mean ±SEM. Significant differences were not detected by one-way ANOVA test with Games-Howell or
Bonferroni post-hoc test. (E) Cumulative distributions of the width, length, and the ratio of width to length of dendritic spines for neurons expressing either mCherry
(control), myosin-IIb-mCherry or myosin-IIb-Y265C-mCherry. Curves are a combination of data points each representing an individual spine. Matching tail regions of
the curves are not shown. *p < 0.05, ***p < 0.001 as determined by pairwise two-sample Kolmogorov-Smirnov test.
FIGURE 7 | Characterization of the inhibitory synapses in DIV15 hippocampal neurons expressing either mCherry (control), wild-type myosin IIb-mCherry or myosin
IIb-Y265C-mCherry and stained with anti-gephyrin antibody. (A) In overlay, mCherry is shown in magenta and anti-gephyrin antibody staining in green. The line
indicates the contour of dendrites (from mCherry). Scale bars, 5µm. (B) Quantification of inhibitory synapse properties. From left to right: (1) Mean density of synapses
calculated as the number of gephyrin puncta per µm of the dendrite: control = 0.37; myosin IIb = 0.45; myosin IIb-Y265C = 0.39. (2) Mean diameter of individual
gephyrin puncta in µm: control = 0.44; myosin IIb = 0.46; myosin IIb-Y265C = 0.42 3. Proportion of the gephyrin puncta located on dendritic spines as a fraction of
the total number of puncta: control=0.33; myosin IIb = 0.43; myosin IIb-Y265C = 0.34. Data in (B) represent n(control) = 17 cells, n(myosin IIb) = 20 cells, n(myosin
IIb-Y265C) = 19 cells, pooled from 3 experiments. *p < 0.05 and **p < 0.01 as determined by one-way ANOVA with Bonferroni’s post-hoc test. Data is represented
as mean ±SEM.
caused a significant change in dendritic spine morphology. This
result confirms the earlier reported spine phenotype (Kalinowska
et al., 2015). The spine phenotypes of autism-linked proteins have
been variable, but, for example, Shank3 overexpression results
in an increase in mushroom spines and in spine head width,
similar to α-actinin-4 (Durand et al., 2012). Based on the results
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FIGURE 8 | Location of the mutated amino acid in the myosin IXb structure. (A) Primary structure of human myosin IXb with the K1872R mutation indicated. (B)
Structure of human myosin IXb (PDB ID 5C5S) with residue K1872 and surrounding residues highlighted (close-up).
of spine analysis, together with published results, we conclude
that wild-type α-actinin-4 (Kalinowska et al., 2015), myosin IIb
(Zhang, 2005; Ryu et al., 2006; Rex et al., 2010; Hodges et al.,
2011), and SrGAP3 (Carlson et al., 2011) have a clear function in
regulating dendritic spine density and morphology (summarized
in Table 2). Although wild-type myosin IXb and SWAP-70 seem
to not have a big impact on spines, this is the first report testing
their possible roles in dendritic spines.
We hypothesized that mutations associated with ASD shift
dendritic spine morphology from mushroom spines to thin
spines. α-actinin-4-M554V mutation resulted in the expected
shift in dendritic spine morphology by increasing the thin spine
density. This change is similar to what was observed upon
the overexpression of ASD-associated Shank3 mutants, which
resulted in mostly thinner spines (Durand et al., 2012). In
addition to significant changes with the ACTN4 mutation, we
saw a trend toward more thin spines with mutations in myosin
IXb and SWAP-70 when compared to wild-type proteins. SWAP-
70-L544F enhanced the induced increase in thin spine density by
the wild-type protein, and the difference between controls and
mutation constructs was statistically significant. The increase in
thin spines is well supported by the fact that SWAP-70-L544F
also increased total spine density and decreased total spine head
size, compared to controls. Total spine head size was significantly
decreased even when the results were compared to wild-type
SWAP-70. Taken together, although most of the changes were
mild and the differences between wild-type and mutated proteins
were not always significant, we observed a trend toward an
increased proportion of thin spines.
Current literature suggests that, compared to bigger
mushroom spines, thin spines are structurally more dynamic
and transient (Kasai et al., 2003; Holtmaat et al., 2005). Thin
spines have weaker synapses than mushroom spines, but
they are more susceptible to potentiation (Matsuzaki et al.,
2004). Mushroom spines with large heads exhibit more AMPA
receptors and stronger excitatory postsynaptic responses
(Matsuzaki et al., 2001), and are stable in vivo over months
(Grutzendler et al., 2002; Trachtenberg et al., 2002; Holtmaat
et al., 2005). These correlations have led to the proposal that
the small dynamic spines are preferentially involved in learning,
whereas larger stable spines mediate long-term memory storage
(Kasai et al., 2003). Thus, it is probable that the most frequently
observed effect of the mutations—the increased density of
thin spines—also affects neuronal function and behavior.
Accordingly, studies on Fragile-X syndrome (FXS) and Shank1
ASD-mouse models have shown a correlation between spine
morphology, neuron functionality, and behavior, supporting
the importance of proper dendritic spine morphology and
density for normal synaptic plasticity and behavior. In the
Fmr1-deficient FXS mouse model, dendritic spines are thin
and elongated and the density is increased (Comery et al.,
1997). Neurons of Fmr1 KO mice exhibit altered synaptic
plasticity (Huber et al., 2002; Zhao et al., 2005; Nosyreva
and Huber, 2006). In the Fmr1 KO synapses, a lower ratio of
AMPA to NMDA receptors was detected early in development
compared to wildtype controls (Pilpel et al., 2009). These data
demonstrate that the lack of Fmr1 produces alterations in
normal synaptic activity, which likely contributes to the FXS
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FIGURE 9 | Characterization of protein localization, dendritic spine density and morphology in DIV14-15 hippocampal neurons expressing EGFP and mCherry
(control), wild-type myosin-IXb-mCherry or mutated myosin-IXb-K1872R-mCherry. (A) Representative maximum projections of confocal Z-stacks for EGFP, mCherry,
and wild-type and mutated myosin IXb localization. Scale bars, 4µm. (B) The quantification of protein localization revealed revealed similar enrichment for both wt and
mutated myosin-IXb to dendritic spines. Spine-to-dendrite fluorescence intensity ratios: control: 0.92 (n = 21 cells, 210 spines), myosin-IXb: 1.65 (n = 18 cells, 180
spines), myosin-IXb-K1872R: 1.61 (n = 14 cells, 140 spines). Center lines show the medians; box limits indicate the 25th and 75th percentiles as determined by R
(Continued)
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FIGURE 9 | software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles, outliers are represented by dots; crosses represent
sample means. ***p < 0.001 as determined by one-way ANOVA test with Games-Howell post-hoc test. (C) Maximum projections of confocal Z-stacks of dendrites
from neurons overexpressing EGFP along with either mCherry, myosin-IXb-mCherry or myosin-IXb-K1872R-mCherry. Only EGFP channel is shown and was used to
assess spine density and morphology. Scale bar, 4µm. (D) Quantification of dendritic spine density calculated as number of spines per 1µm of dendrite. The first left
cluster of bars represents total spine density. Densities of thin, mushroom, stubby, and total spines were as follows: wt: thin = 0.24, mushroom = 0.18, stubby =
0.07, total = 0.48 spines/µm (n = 21 neurons, 1,567 spines, 3,321µm dendrite); myosin-IXb: thin = 0.24, mushroom = 0.15, stubby = 0.06, total = 0.44 spines/µm
(n = 18 neurons, 1,059 spines, 2,475µm dendrite); myosin-IXb-K1872R: thin = 0.27, mushroom = 0.15, stubby = 0.06, total = 0.49 spines/µm (n = 14 neurons,
1,006 spines, 2,120µm dendrite). Data is pooled from 3 experiments and represented as mean ±SEM. Significant differences were not detected by one-way ANOVA
test with Bonferroni post-hoc test. (E) Cumulative distributions of the width, length, and the ratio of width to length of dendritic spines for neurons expressing either
mCherry (control), myosin-IXb-mCherry or myosin-IXb-K1872R-mCherry. Curves are a combination of data points each representing an individual spine. Matching tail
regions of the curves are not shown. **p < 0.01, ***p < 0.001 as determined by pairwise two-sample Kolmogorov-Smirnov test.
FIGURE 10 | Characterization of the inhibitory synapses in DIV15 hippocampal neurons expressing either mCherry (control), wild-type myosin IXb-mCherry or myosin
IXb-K1872R-mCherry and stained with anti-gephyrin antibody. (A) In overlay, mCherry is shown in magenta and anti-gephyrin antibody staining in green. The line
indicates the contour of dendrites (from mCherry). Scale bars, 5µm. (B) Quantification of inhibitory synapse properties. From left to right: (1) Mean density of synapses
calculated as the number of gephyrin puncta per µm of the dendrite: control = 0.37; myosin IXb = 0.37; myosin IXb-K1872R = 0.40. (2) Mean diameter of individual
gephyrin puncta in µm: control = 0.44; myosin IXb = 0.48; myosin IXb-K1872R = 0.44 3. Proportion of the gephyrin puncta located on dendritic spines as a fraction
of the total number of puncta: control = 0.33; myosin IXb = 0.41; myosin IXb-K1872R = 0.39. Data in (B) represent n(control) = 17 cells, n(myosin IXb) = 24 cells,
n(myosin IXb-K1872R) = 24 cells, pooled from 2 experiments. *p < 0.05 as determined by one-way ANOVA with Bonferroni’s post-hoc test. Data is represented as
mean ± SEM.
phenotype. Behavioral analyses have revealed autism-related
behavior, such as hyperactivity, repetitive behaviors, and seizures
(reviewed in Kazdoba et al., 2014). By rescuing the spine
density or morphology, autism-related behavior was rescued
(Dolan et al., 2013; Pyronneau et al., 2017). Shank1-KO mice
showed thinner dendritic spines, smaller excitatory synapses,
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FIGURE 11 | Characterization of protein localization, dendritic spine density and morphology in DIV14-15 hippocampal neurons expressing EGFP and mCherry
(control), wild-type SWAP-70-mCherry or mutated SWAP-70-L544F-mCherry. (A) Primary structure of human SWAP-70 with mutation L544F indicated. (B)
Representative maximum projections of confocal Z-stacks for EGFP, mCherry, and wild-type and mutated SWAP-70 localization. Scale bars 4µm. (C) The
(Continued)
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FIGURE 11 | quantification of protein localization revealed slightly enriched localization of wt SWAP-70 and the clear accumulation of SWAP-70-L544F in dendritic
spines. Spine-to-dendrite fluorescence intensity ratios: control: 0.98 (n = 15 cells, 147 spines), SWAP-70: 1.15 (n = 15 cells, 173 spines), SWAP-70-L544F: 1.78 (n =
18 cells, 180 spines). Center lines show the medians; box limits indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the
interquartile range from the 25th and 75th percentiles, outliers are represented by dots; crosses represent sample means. **p < 0.01, ***p < 0.001 as determined by
one-way ANOVA test with Bonferroni post-hoc test. (D) Maximum projections of confocal Z-stacks of dendrites from neurons overexpressing EGFP along with either
mCherry, SWAP-70-mCherry or SWAP-70-L544F-mCherry. Only EGFP channel is shown and was used to assess spine density and morphology. Control image is
re-used from Figure 2C. Scale bar, 4µm. (E) Quantification of dendritic spine density calculated as number of spines per 1µm of dendrite. The first left cluster of bars
represents total spine density. Densities of thin, mushroom, stubby, and total spines were as follows: wt: thin = 0.19, mushroom = 0.16, stubby = 0.04, total = 0.39
spines/µm (n = 15 neurons, 753 spines, 1,994µm dendrite); SWAP-70: thin = 0.25, mushroom = 0.18, stubby = 0.03, total = 0.46 spines/µm (n = 16 neurons,
762 spines, 1,780µm dendrite); SWAP-70-L544F: thin = 0.31, mushroom = 0.18, stubby = 0.05, total = 0.54 spines/µm (n = 20 neurons, 1,403 spines, 2,672µm
dendrite). Data is pooled from 2 experiments and represented as mean ±SEM. *p < 0.05, **p < 0.01 as determined by one-way ANOVA test with Bonferroni
post-hoc test. (F) Cumulative distributions of the width, length and the ratio of width to length of dendritic spines for neurons expressing either mCherry (control),
SWAP-70-mCherry or SWAP-70-L544F-mCherry. Curves are a combination of data points each representing an individual spine. Matching tail regions of the curves
are not shown. *p < 0.05, **p < 0.01, ***p < 0.001 as determined by pairwise two-sample Kolmogorov-Smirnov test.
FIGURE 12 | Characterization of the inhibitory synapses in DIV15 hippocampal neurons expressing either mCherry (control), wild-type SWAP-70-mCherry or
SWAP-70-L544F-mCherry and stained with anti-gephyrin antibody. (A) In overlay, mCherry is shown in magenta and anti-gephyrin antibody staining in green. The line
indicates the contour of dendrites (from mCherry). Scale bars, 5µm. (B) Quantification of inhibitory synapse properties. From left to right: (1) Mean density of synapses
calculated as the number of gephyrin puncta per µm of the dendrite: control = 0.38; SWAP-70 = 0.38; SWAP-70-L544F = 0.28. (2) Mean diameter of individual
gephyrin puncta in µm: control = 0.42; SWAP-70 = 0.38; SWAP-70-L544F = 0.40 3. Proportion of the gephyrin puncta located on dendritic spines as a fraction of
the total number of puncta: control = 0.34; SWAP-70 = 0.37; SWAP-70-L544F = 0.34. Data in B represent n(control) = 21 cells, n(SWAP-70) = 23 cells,
n(SWAP-70-L544F) = 26 cells, pooled from 4 experiments. *p < 0.05 as determined by one-way ANOVA with Bonferroni’s post-hoc test. Data is represented as
mean ±SEM.
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FIGURE 13 | Characterization of protein localization, dendritic spine density and morphology in DIV14-15 hippocampal neurons expressing EGFP and mCherry
(control), wild-type SrGAP3-mCherry or mutated SrGAP3-E469K-mCherry. (A) Primary structure of human SrGAP3 with mutation E469K indicated. (B) Representative
maximum projections of confocal Z-stacks for EGFP, mCherry, and wild-type and mutated SrGAP3 localization. Scale bars 4µm. (C) The quantification of protein
(Continued)
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FIGURE 13 | localization revealed similar localization of both wt and mutated SrGAP3 to dendritic spines. Spine-to-dendrite fluorescence intensity ratios: control: 0.99
(n = 34 neurons, 337 spines), SrGAP3: 1.32 (n = 25 neurons, 257 spines), SrGAP3-E469K: 1.42 (n = 23 neurons, 229 spines). Center lines show the medians; box
limits indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles, outliers
are represented by dots; crosses represent sample means. **p < 0.01, ***p < 0.001 as determined by one-way ANOVA test with Games-Howell post-hoc test. (D)
Maximum projections of confocal Z-stacks of dendrites from neurons overexpressing EGFP along with either mCherry, SrGAP3-mCherry or SrGAP3-E469K-mCherry.
Only EGFP channel is shown and was used to assess spine density and morphology. Scale bar, 4µm. (E) Quantification of dendritic spine density calculated as
number of spines per 1µm of dendrite. The first left cluster of bars represents total spine density. Densities of thin, mushroom, stubby, and total spines were as follows:
wt: thin = 0.23, mushroom = 0.16, stubby = 0.06, total = 0.45 spines/µm (n = 34 neurons, 1,459 spines, 3,401µm dendrite); SrGAP3: thin = 0.29, mushroom =
0.19, stubby = 0.07, total = 0.54 spines/µm (n = 25 neurons, 1,431 spines, 2,792µm dendrite); SrGAP3-E469K: thin = 0.28, mushroom = 0.19, stubby = 0.07,
total = 0.54 spines/µm (n = 23 neurons, 1,087 spines, 2,025µm dendrite). Data is pooled from 3 experiments and represented as mean ±SEM. *p < 0.05 as
determined by one-way ANOVA test with Games-Howell post-hoc test. (F) Cumulative distributions of the width, length and the ratio of width to length of dendritic
spines for neurons expressing either mCherry (control), SrGAP3-mCherry or SrGAP3-E469K-mCherry. Curves are a combination of data points each representing an
individual spine. Matching tail regions of the curves are not shown. Significant differences were not detected by pairwise two-sample Kolmogorov-Smirnov test.
FIGURE 14 | Characterization of the inhibitory synapses in DIV15 hippocampal neurons expressing either mCherry (control), wild-type SrGAP3-mCherry or
SrGAP3-E469K-mCherry and stained with anti-gephyrin antibody. (A) In overlay, mCherry is shown in magenta and anti-gephyrin antibody staining in green. The line
indicates the contour of dendrites (from mCherry). Scale bars, 5µm. (B) Quantification of inhibitory synapse properties. From left to right: (1) Mean density of synapses
calculated as the number of gephyrin puncta per µm of the dendrite: control = 0.37; SrGAP3 = 0.41; SrGAP3-E469K = 0.51. (2) Mean diameter of individual gephyrin
puncta in µm: control = 0.44; SrGAP3 = 0.38; SrGAP3-E469K = 0.39. 3. Proportion of the gephyrin puncta located on dendritic spines as a fraction of the total
number of puncta: control = 0.33; SrGAP3 = 0.33; SrGAP3-E469K = 0.42. Data in B represent n(control) = 17 cells, n(SrGAP3) = 19 cells, n(SrGAP3-E469K) = 18
cells, pooled from 3 experiments. *p < 0.05 and **p < 0.01 as determined by one-way ANOVA with Bonferroni’s post-hoc test. Data is represented as mean ±SEM.
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and weaker basal synaptic transmission (Hung et al., 2008). In
contrast to FXS mice, synaptic plasticity was normal in these
mice. Behaviorally, they had increased anxiety-related behavior
and impaired contextual fear memory (Hung et al., 2008). In
line with the idea that small dynamic spines are preferentially
involved in learning, whereas larger stable spines mediate
long-term memory storage (Kasai et al., 2003), Shank1-deficient
mice displayed enhanced performance in a spatial learning
task but their long-term memory was impaired (Hung et al.,
2008).
Finally, we analyzed the size, density, and localization of
inhibitory synapses. In addition to increasing our knowledge of
the effects of ASD-mutations, we provide here new information
for whether actin binding proteins in general affect inhibitory
synapses. This is still a very poorly characterized field and
these results may open new avenues for actin regulation of
inhibitory synapses. Changes in inhibitory synapses varied
between the proteins studied. Myosin IIb and myosin IXb
increased the proportion of inhibitory synapses in spines,
whereas SrGAP3 decreased the size of inhibitory synapses.
Thus, it seems that actin-binding proteins can affect various
parameters in inhibitory synapses but the detailed molecular
mechanisms are still open. In the future, it will also be
interesting to see whether the spiny localization of inhibitory
synapses will affect the inhibition efficiency or modality of the
synapses. Currently, it seems that positions of shaft inhibitory
synapses determine the hotspots of synapse remodeling, where
both new spines and new inhibitory synapses are more
likely to be formed (Chen et al., 2012; Isshiki et al., 2014).
Furthermore, inhibitory synapses in spines seem to stabilize
spines (Isshiki et al., 2014). In line with this result, the
loss of inhibitory synapses from spines could indicate an
increased turnover rate of spines. This is interesting in the
context of ASD as an increased turnover of spines was
found to be a common parameter for two tested ASD-mouse
models (Isshiki et al., 2014). Here, the expression of mutated
myosin IIb (Y265C) reduced, but mutated SrGAP3 (E469K)
increased, the proportion of inhibitory synapses in spines
(Table 2). In addition, α-actinin-4, myosin IXb, and SWAP-
70 mutations showed a trend toward a reduced proportion
of spiny inhibitory synapses. Furthermore, the expression of
myosin IIb-Y265C decreased the inhibitory synapse size and
SWAP-70-L544F expression decreased the density of inhibitory
synapses.
It is important to note that although we did not observe
changes in dendritic spines or inhibitory synapses for all
mutations, it is possible that the mutations do affect synaptic
transmission and behavior. The effects of the mutations are
obviously not restricted to synapses, but mutations can affect
other cellular processes in the brain, from dendrite growth
to the various functions of glial cells. Functional defects
of glial cells are implicated in ASD (Petrelli et al., 2016)
and, in fact, all genes studied here are expressed in higher
levels in human astrocytes than in neurons (Zhang et al.,
2014).
With overexpression analysis in cultured neurons we can
only determine whether a mutation changes the protein’s
function. Proper evaluation of the contribution of a mutation
to the development of autism requires knock-in animal
studies. A very nice example of this is a thorough evaluation
of SHANK3 ASD and schizophrenia mutations in mouse
models showing both shared and distinct defects in synaptic
transmission, behavior, and spine density (Zhou et al., 2016).
However, these type of studies are time-consuming and
require plenty of resources. Therefore, the pre-screening of
mutations is necessary to pre-select mutations for detailed
studies. Furthermore, our screening-type experiments give a
broader view on the impact of de novo missense mutations
and which cellular parameters should and could be used as
readouts for protein functionality. From these five genes,
only the α-actinin-4 mutation showed a substantial effect
on dendritic spines and should be taken to further animal
studies. The effects of all the other mutations were relatively
mild, but it is possible that under suitable circumstances,
possibly enhanced by other mutations or risk-variants,
these mutations can contribute to the development of
autism.
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